Literature DB >> 19545173

Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones.

Lan Tang1, Rashim Singh, Zhongqiu Liu, Ming Hu.   

Abstract

We characterized the isoform specific glucuronidation of six isoflavones, genistein, daidzein, glycitein, formononetin, biochanin A and prunetin, using 12 expressed human UGTs and human intestinal and liver microsomes. The results indicated that these isoflavones are metabolized most rapidly at three different concentrations by one of these four UGT isoforms: UGT1A1, UGT1A8, UGT1A9 and UGT1A10. Furthermore, glycitein was usually metabolized the fastest whereas prunetin the slowest. Using the rates of metabolism by 12 UGT isoforms as a means to establish the metabolic "fingerprint", we found that each isoflavone had distinctive concentration-dependent patterns. Determination of kinetic parameters of glucuronidation using genistein and prunetin indicated that the distinct concentration-dependent metabolic patterns were the result of differences in K(m) and V(max) values. We then measured how well metabolic "fingerprinting" predicted metabolism of these isoflavones by human intestinal and liver microsomes. We found that the prediction was rather successful for five isoflavones in the liver microsomes, but not successful in the intestinal microsomes. We propose that a newly discovered UGT3A1 isoform capable of metabolizing phenols and estrogens might be responsible for the metabolism of isoflavones such as formononetin in humans. In conclusion, the first systematic study of metabolic "fingerprinting" of six common isoflavones showed that each isoflavone has UGT isoform-specific metabolic patterns that are concentration-dependent and predictive of metabolism of the isoflavones in liver microsomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545173      PMCID: PMC2941769          DOI: 10.1021/mp8002557

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  26 in total

Review 1.  Coupling of conjugating enzymes and efflux transporters: impact on bioavailability and drug interactions.

Authors:  Eun Ju Jeong; Xing Liu; Xiaobin Jia; Jun Chen; Ming Hu
Journal:  Curr Drug Metab       Date:  2005-10       Impact factor: 3.731

2.  An extract of the Chinese herbal root kudzu reduces alcohol drinking by heavy drinkers in a naturalistic setting.

Authors:  Scott E Lukas; David Penetar; Jeff Berko; Luke Vicens; Christopher Palmer; Gopinath Mallya; Eric A Macklin; David Y-W Lee
Journal:  Alcohol Clin Exp Res       Date:  2005-05       Impact factor: 3.455

Review 3.  Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.

Authors:  Michael Murray
Journal:  J Pharm Pharmacol       Date:  2006-07       Impact factor: 3.765

4.  Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties.

Authors:  Stephen W J Wang; Jun Chen; Xiaobin Jia; Vincent H Tam; Ming Hu
Journal:  Drug Metab Dispos       Date:  2006-08-01       Impact factor: 3.922

5.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

6.  Disposition of flavonoids via recycling: comparison of intestinal versus hepatic disposition.

Authors:  Jun Chen; Stephen Wang; Xiaobin Jia; Susan Bajimaya; Huimin Lin; Vincent H Tam; Ming Hu
Journal:  Drug Metab Dispos       Date:  2005-08-24       Impact factor: 3.922

Review 7.  Dietary polyphenolic phytochemicals--promising cancer chemopreventive agents in humans? A review of their clinical properties.

Authors:  Sarah C Thomasset; David P Berry; Giuseppe Garcea; Timothy Marczylo; William P Steward; Andreas J Gescher
Journal:  Int J Cancer       Date:  2007-02-01       Impact factor: 7.396

8.  Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model.

Authors:  Jun Chen; Huimin Lin; Ming Hu
Journal:  Cancer Chemother Pharmacol       Date:  2004-09-29       Impact factor: 3.333

9.  Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction.

Authors:  Shuji Ohno; Shizuo Nakajin
Journal:  Drug Metab Dispos       Date:  2008-10-06       Impact factor: 3.922

Review 10.  Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.

Authors:  Sonu Sundd Singh
Journal:  Curr Drug Metab       Date:  2006-02       Impact factor: 3.731

View more
  35 in total

1.  Sulfation of selected mono-hydroxyflavones by sulfotransferases in vitro: a species and gender comparison.

Authors:  Cai Hua Yang; Lan Tang; Chang Lv; Ling Ye; Bi Jun Xia; Ming Hu; Zhong Qiu Liu
Journal:  J Pharm Pharmacol       Date:  2011-07       Impact factor: 3.765

2.  Inhibition of genistein glucuronidation by bisphenol A in human and rat liver microsomes.

Authors:  Janis L Coughlin; Paul E Thomas; Brian Buckley
Journal:  Drug Metab Dispos       Date:  2011-12-06       Impact factor: 3.922

3.  Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC-MS/MS method: Application to an oral bioavailability study of genistein in mice.

Authors:  Zhen Yang; Wei Zhu; Song Gao; Haiyan Xu; Baojian Wu; Kaustubh Kulkarni; Rashim Singh; Lan Tang; Ming Hu
Journal:  J Pharm Biomed Anal       Date:  2010-03-16       Impact factor: 3.935

Review 4.  Bioavailability challenges associated with development of anti-cancer phenolics.

Authors:  Song Gao; Ming Hu
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

5.  Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes.

Authors:  Lan Tang; Ling Ye; Rashim Singh; Baojian Wu; Chang Lv; Jie Zhao; Zhongqiu Liu; Ming Hu
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

6.  Accurate prediction of glucuronidation of structurally diverse phenolics by human UGT1A9 using combined experimental and in silico approaches.

Authors:  Baojian Wu; Xiaoqiang Wang; Shuxing Zhang; Ming Hu
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

7.  Uridine diphosphate glucuronosyltransferase isoform-dependent regiospecificity of glucuronidation of flavonoids.

Authors:  Rashim Singh; Baojian Wu; Lan Tang; Ming Hu
Journal:  J Agric Food Chem       Date:  2011-06-06       Impact factor: 5.279

Review 8.  Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis.

Authors:  Baojian Wu; Sumit Basu; Shengnan Meng; Xiaoqiang Wang; Ming Hu
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

9.  Evaluation of 3,3',4'-trihydroxyflavone and 3,6,4'-trihydroxyflavone (4'-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1.

Authors:  Baojian Wu; Shuxing Zhang; Ming Hu
Journal:  Mol Pharm       Date:  2011-10-21       Impact factor: 4.939

10.  Quantitation of celecoxib and four of its metabolites in rat blood by UPLC-MS/MS clarifies their blood distribution patterns and provides more accurate pharmacokinetics profiles.

Authors:  Yong Ma; Song Gao; Ming Hu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-07-19       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.